Category:
Chiral Intermediates
CAS NO:
96829-58-2
Standard:
ChP,
Orlistat chiral intermediates are key asymmetric building blocks for the synthesis of orlistat, a lipase inhibitor. These compounds typically involve specific stereoisomers derived from (S)-N-(benzyloxycarbonyl)-L-leucine derivatives. The molecular formula is generally C16H25NO4, with CAS No. 89730-73-2 for the primary intermediate.
Storage requires sealed containers at 2-8°C to prevent racemization. Handling necessitates PPE due to potential sensitization. Strict adherence to GMP guidelines is mandatory during clinical supply chain integration.